Securities code: Hunan Warrant Pharmaceutical Co.Ltd(688799) securities abbreviation: Hunan Warrant Pharmaceutical Co.Ltd(688799) Announcement No.: 2022006 Hunan Warrant Pharmaceutical Co.Ltd(688799)
Announcement of resolutions of the third meeting of the third board of supervisors
The board of supervisors and all supervisors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal liabilities for the authenticity, accuracy and integrity of its contents in accordance with the law.
1、 Meetings of the board of supervisors
Hunan Warrant Pharmaceutical Co.Ltd(688799) (hereinafter referred to as “the company”) the third meeting of the third board of supervisors was held on March 26, 2022 by means of on-site combined communication. The notice of this meeting was sent to all supervisors of the company by e-mail on March 15, 2022. The meeting was presided over by Mr. Jin Yan, the chairman of the board of supervisors. There were 3 supervisors who should attend the meeting and 3 supervisors who actually attended the meeting. The convening, convening and voting procedures of the meeting comply with the relevant laws and regulations and the Hunan Warrant Pharmaceutical Co.Ltd(688799) articles of Association (hereinafter referred to as the “articles of association”), and the resolutions made are legal and effective.
2、 Deliberation at the meeting of the board of supervisors
The following proposals were considered and adopted at this meeting:
(I) deliberated and passed the proposal on the company’s 2021 annual report and its summary
For details, the company published it on the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) Annual report of Hunan Warrant Pharmaceutical Co.Ltd(688799) 2021 and summary of annual report of Hunan Warrant Pharmaceutical Co.Ltd(688799) 2021.
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation.
(II) deliberated and passed the proposal on the work report of the board of supervisors in 2021
For details, the company published it on the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) Work report of the board of supervisors for Hunan Warrant Pharmaceutical Co.Ltd(688799) 2021.
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation.
(III) deliberated and passed the proposal on the special report on the deposit and use of the company’s raised funds in 2021
For details, the company published it on the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) Special report of Hunan Warrant Pharmaceutical Co.Ltd(688799) board of directors on the deposit and use of raised funds in 2021.
Voting results: 3 in favor, 0 against and 0 abstention.
(IV) deliberated and passed the proposal on the company’s 2021 financial final accounts and 2022 financial budget report
For details, the company published it on the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) Financial final accounts of Hunan Warrant Pharmaceutical Co.Ltd(688799) 2021 and financial budget report of 2022.
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation.
(V) review and approve the company’s profit distribution plan for 2021
For details, the company published it on the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) Announcement of Hunan Warrant Pharmaceutical Co.Ltd(688799) on the company’s annual profit distribution plan in 2021.
Voting results: 3 in favor, 0 against and 0 abstention.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation.
(VI) the proposal on the confirmation of related party transactions in 2021 and the prediction of related party transactions in 2022 was deliberated and adopted
For details, the company published it on the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) Announcement of Hunan Warrant Pharmaceutical Co.Ltd(688799) on confirmation of related party transactions in 2021 and prediction of related party transactions in 2022.
Voting result: Associate supervisor Xie Jun avoided voting. 2 in favor, 0 against, 0 abstention and 1 avoidance.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation.
(VII) review the proposal on the remuneration plan of the company’s supervisors in 2022
For details, the company published it on the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) Announcement of Hunan Warrant Pharmaceutical Co.Ltd(688799) on the remuneration scheme of directors, supervisors and senior managers in 2022. Voting result: all supervisors of this proposal have avoided voting.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation.
(VIII) deliberated and passed the proposal on the change of accounting policies of the company
For details, the company published it on the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) Announcement of Hunan Warrant Pharmaceutical Co.Ltd(688799) on changes in accounting policies.
Voting results: 3 in favor, 0 against and 0 abstention.
It is hereby announced.
Hunan Warrant Pharmaceutical Co.Ltd(688799) board of supervisors March 29, 2022
